Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Glycol chitosan Nanoparticles
100%
Extracellular Matrix
100%
Collagen
100%
Intracellular Delivery
100%
Chitosan Nanoparticles
100%
Human Lung Fibroblasts
100%
Idiopathic Pulmonary Fibrosis
85%
Fibroblasts
57%
Lung Fibroblasts
57%
Cellular Uptake
42%
Macropinocytosis
42%
Nanoparticles
28%
Type I Collagen
28%
Cellular Delivery
28%
Amiloride
28%
Collagen Matrix
28%
Pathological Microenvironment
28%
Phosphoinositide 3-kinase (PI3K)
14%
Phosphatidylinositol 3-kinase Inhibitor
14%
Genistein
14%
Nanomedicine
14%
Clathrin-mediated Endocytosis
14%
Kinase Activity
14%
Targeted Therapy
14%
Caveolae-mediated Endocytosis
14%
Lung Disease
14%
Non-idiopathic
14%
Biological Behavior
14%
Chlorpromazine
14%
Chronic Lung Disease
14%
Drug Carrier System
14%
Primary Human Lung Fibroblasts
14%
Medicine and Dentistry
Extracellular Matrix
100%
Chitosan Nanoparticle
100%
Lung Fibroblast
100%
Idiopathic Pulmonary Fibrosis
66%
Fibroblast
44%
Macropinocytosis
33%
Endocytosis
22%
Collagen Type 1
22%
Amiloride
22%
Nanoparticle
22%
In Vitro
11%
Phosphoinositide 3-Kinase
11%
Phosphoinositide 3-Kinase Inhibitor
11%
Nanomedicine
11%
Targeted Therapy
11%
Silo-Filler's Disease
11%
Caveolae
11%
Drug Carrier
11%
Internalization
11%
Clathrin
11%
Chronic Lung Disease
11%
Genistein
11%
Chlorpromazine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chitosan Nanoparticle
100%
Fibrosing Alveolitis
66%
Nanoparticle
22%
Collagen Type 1
22%
Amiloride
22%
Phosphatidylinositol 3 Kinase
11%
Phosphatidylinositol 3 Kinase Inhibitor
11%
Nanomedicine
11%
Drug Carrier
11%
Genistein
11%
Lung Disease
11%
Clathrin
11%
Chronic Lung Disease
11%
Chlorpromazine
11%